Moolec Science MLECW
NASDAQ MLECW
$0.02 +0.00 (+2.56%)
As of: Aug 19, 2026 · 2:06 PM EDT

Moolec Science (MLECW) Net Margin (2022 - 2024)

Moolec Science (MLECW) posted Net Margin of 22.53% for Q4 2024, up 117.79% sequentially from 126.62% in Q3 2024, and down 318277.0% YoY from N/an in Q1 2024.

Moolec Science (MLECW) Net Margin (2022 - 2024) Analysis & Trends

Moolec Science has reported Net Margin for 3 years, with the latest figure at 22.53% in Q4 2024.

  • Quarterly Net Margin fell 318277.0% year-over-year to 22.53% in Q4 2024, while the trailing twelve-month figure through Dec 2024 was 101.87% (down 13591.0% YoY) and the FY2024 annual result came in at 584.44%, down 505225.0% from the prior year.
  • Net Margin improved to 22.53% in Q4 2024 per MLECW's latest filing, from 126.62% in the prior quarter.
  • Over five years, Net Margin peaked at 582903.29% in Q2 2022 and troughed at 501839.99% in Q4 2022.
  • A 3-year average of 7968.67% and a median of 36.85% in 2024 frame the typical range for Net Margin.
  • The widest YoY moves for Net Margin: up 50504528 bps in 2023, down 58285211 bps in 2023.
  • Over 3 years, Net Margin stood at 501839.99% in 2022, then surged by 101 bps to 3205.29% in 2023, then sank by 99 bps to 22.53% in 2024.
  • According to Business Quant data, Net Margin over the past three periods registered 22.53%, 126.62%, and 358.14% for Q4 2024, Q3 2024, and Q2 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 32.99%
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 30.23%
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 31.16%
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -539.31%
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 13.90%
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 12.74%
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -16.51%
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -3.12%
9 Royalty Pharma 27.27 Bn 26.43 Bn - 12.09%
10 Moolec Science 8,617.72 -1.19 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 22.53%
Sep 30, 2024 -126.62%
Jun 30, 2024 -358.14%
Mar 31, 2024 -54.43%
Dec 31, 2023 3,205.29%
Sep 30, 2023 -103.81%
Jun 30, 2023 51.18%
Mar 31, 2023 1,271.78%
Dec 31, 2022 -501,839.99%
Sep 30, 2022 6,273.27%
Jun 30, 2022 582,903.29%
Mar 31, 2022 4,379.63%